MedPath

Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.

Phase 3
Completed
Conditions
Essential Hypertension
Interventions
Combination Product: Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg
Registration Number
NCT05288400
Lead Sponsor
Servier
Brief Summary

The purpose of this study was to evaluate the efficacy and the safety of a fixed-dose combination in capsule of Amlodipine 5mg/ Bisoprolol fumarate 5mg/ Perindopril arginine 5mg, and free monotherapy at the same dose in patients with uncontrolled essential hypertension.

Detailed Description

This was a phase III, multicenter, randomized, open-label, controlled study, over a 12-week treatment period with a single-capsule of fixed dose combination (FDC) of Amlodipine 5 mg/ Bisoprolol fumarate 5 mg / Perindopril arginine 5 mg and free monocomponents of Amlodipine 5 mg, Bisoprolol fumarate 5 mg and Perindopril arginine 5 mg given concomitantly, in 150 patients with uncontrolled essential HT.

Patients without any non-selection criteria, already treated by anti-hypertensive monotherapy at maximal dose or either by a dual therapy at minimum dose, other than study treatment, having an uncontrolled HT defined by SBP (Systolic Blood Pressure) ≥ 140 and \<160 mmHg and DBP (Diastolic Blood Pressure) ≥ 90 and \<100 mmHg (in supine position) at 2 different visits (selection and inclusion) were to be selected in this study and randomized to one of two treatment groups: single-capsule combination or free therapy without any wash-out period.

For all patients, controlled blood pressure (BP) was defined as SBP \< 140 mmHg and DBP \< 90 mmHg.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group AAmlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mgsingle-capsule of fixed dosed combination (FDC) of amlodipine 5 mg / bisoprolol fumarate 5 mg / perindopril arginine 5 mg
Group BNorvasc 5mg tabletFree triple therapy of amlodipine 5 mg + bisoprolol fumarate 5 mg + perindopril arginine 5 mg, given concomitantly
Group BConcor 5mg tabletFree triple therapy of amlodipine 5 mg + bisoprolol fumarate 5 mg + perindopril arginine 5 mg, given concomitantly
Group BCoversyl 5mg tabletFree triple therapy of amlodipine 5 mg + bisoprolol fumarate 5 mg + perindopril arginine 5 mg, given concomitantly
Primary Outcome Measures
NameTimeMethod
Change from baseline of blood pressure (SBP and DBP)at baseline, 4, 8 and 12 weeks
Secondary Outcome Measures
NameTimeMethod
Assessment of patient treatment satisfaction TSQM-9 questionnaire12 weeks
Blood pressure control rate (SBP < 140 mmHg and DBP < 90 mmHg)at 4, 8 and 12 weeks
Response rate for antihypertensive therapyat 4, 8 and 12 weeks

Rate of patients with supine blood pressure normalized (SBP \<140 mmHg and DBP \<90 mmHg) or decrease of SBP ≥20 mmHg and/or decrease of DBP ≥10 mmHg from baseline

Trial Locations

Locations (15)

Problems of Cardiovascular Diseases" 6 Sosnovy Bulvar St.

🇷🇺

Kemerovo, Russian Federation

Autonomous non-profit organization "Medical Center "Alliance" 12 Molodezhnaya St., 12

🇷🇺

Kirovsk, Russian Federation

Regional state budget health care institution "Altai Regional Cardiological dispensary" 46 Malakhova St.

🇷🇺

Barnaul, Altai Region, Russian Federation

St. Petersburg State Budgetary Healthcare Institution "The city hospital No.38. named after N.A. Semashko" 7/2 letter A Gospitalnaya Str., Pushkin

🇷🇺

Saint Pertersburg, Russian Federation

LLC "Medicinskie tekhnologii", Nevzorova street, 6/191025, Saint-Petersburg, Vosstania street, 8 lit A

🇷🇺

Saint Petersburg, Russian Federation

Saint-Petersburg State Budgetary Healthcare Institution "City outpatient clinic №109" 8 bld. 2 Oleko Dundicha

🇷🇺

Saint Petersburg, Russian Federation

State budgetary healthcare institution of city of Moscow "City polyclinic #2 of Healthcare Department of city of Moscow" 12 Fruktovaya St.

🇷🇺

Moscow, Russian Federation

Federal State Budgetary Institution ''Ourpatient clinic #5'' of the Administration of the President of the Russian Federation 14 Plyushchikha St.

🇷🇺

Moscow, Russian Federation

Pavlov First Saint Petersburg State Medical University L'va Tolstogo str. 6-8

🇷🇺

Saint Pertersburg, Russian Federation

Federal State Budgetary Institution "North-West Federal Medical Research Center n.a. V.A. Almazov" of the Ministry of Health of the Russian Federation 2 Akkuratova St.

🇷🇺

Saint Petersburg, Russian Federation

LLC "Strategicheskie Medicinskie Sistemy", Nevzorova street, 6

🇷🇺

Saint Petersburg, Russian Federation

Limited Liability Company "MART" 54 bld. 3 Let. J Maly Prospekt V.O

🇷🇺

Saint Petersburg, Russian Federation

The Federal State Budgetary Institute "The Nikiforov Russian Center of Emergency and Radiation Medicine" The Ministry of Russian Federation for Civil Defense, Emergencies and Elimination of Consequences of Natural Disasters

🇷🇺

Saint Petersburg, Russian Federation

St. Petersburg State Budgetary Healthcare Institution "City Consulting and Diagnostic Center No. 85" 89 bld. 3 Let. A Prospekt Veteranov

🇷🇺

Saint-Petersburg, Russian Federation

Limited Liability Company "Medical Research Institute" 25 Let. A 3 Kolya Tomchak St.

🇷🇺

Saint Petersburg, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath